Results 281 to 290 of about 789,387 (385)

Optogenetic‐Controlled iPSC‐Based Vaccines for Prophylactic and Therapeutic Tumor Suppression in Mice

Advanced Science, EarlyView.
This study develops an a red/far‐red light‐controlled iPSC‐based vaccines (RIVA) based on the chimeric photosensory protein FnBphP and its interaction partner LDB3 for cancer immunotherapy. The RIVA preserves the multiple intrinsic tumor antigens of iPSCs and enables optogenetic control of the expression of the immune adjuvant type I interferon β under
Longliang Qiao, Lingxue Niu, Zhihao Wang, Di Dai, Shasha Tang, Xiaoding Ma, Zhenqiang Deng, Guiling Yu, Yang Zhou, Tao Yan, Xingwan Liu, Deqiang Kong, Linfeng Hu, Xiang Li, Junwei Zhao, Fengfeng Cai, Meiyan Wang, Haifeng Ye   +17 more
wiley   +1 more source

Cervical, Breast, and Colorectal Cancer Screening Rates Among Sexual and Gender Minority Women in Japan: Using a Nationwide Online Survey. [PDF]

Health Sci Rep
Matsushima M, Wang J, Minami T, Yamada H, Kondo N, Tabuchi T.   +5 more
europepmc   +1 more source

The diagnostic value of upper endoscopy in veterans undergoing colorectal cancer screening with fecal occult blood testing

, 2000
Lauren B. Gerson, Katerina Shetler, Roopali Bansal, Ramsey Cheung   +3 more
openalex   +1 more source

Comparative Analysis of Clinical Outcomes and Financial Aspects of Phototherapies and Immunotherapy for Cancer

Advanced Science, EarlyView.
This review compares clinical outcomes, translational progress, and global funding trends across cancer phototherapies—photodynamic, photothermal, and photoimmunotherapy—and conventional immunotherapy. It highlights differences in treatment efficacy, clinical trial status, financial investment, and regulatory challenges, providing a comprehensive ...
Deepak S. Chauhan, Kun Shao, Roopa Hebbandi Nanjundappa, Daniel‐Jiajun Yu, Marianne Stanford, Huile Gao, Channakeshava Sokke Umeshappa   +6 more
wiley   +1 more source

Cost effectiveness analysis of three colorectal cancer screening modalities in Kuwait. [PDF]

Sci Rep
Nur AM, Aljunid SM, Tolma EL, Annaka M, Alwotayan R, Elbasmi A, Alali WQ.   +6 more
europepmc   +1 more source

PCH5: COST-EFFECTIVENESS OF EARLY DETECTION AND PREVENTION OF COLORECTAL CANCER BY SCREENING WITH FECAL OCCULT BLOOD TESTS

, 2000
RE Parson, JT Baker
openalex   +1 more source

Download the PDF of the Full Issue [PDF]

, 2008

core   +1 more source

MTCH2 Deficiency Promotes E2F4/TFRC‐Mediated Ferroptosis and Sensitizes Colorectal Cancer Liver Metastasis to Sorafenib

Advanced Science, EarlyView.
This study identifies MTCH2 as a crucial regulator of ferroptosis in colorectal cancer (CRC) progression. High expression of MTCH2 is correlated with poor prognosis in CRC patients. Furthermore, MTCH2 depletion induces ferroptosis to suppress CRC liver metastasis via the E2F4/TFRC axis and sensitizes tumors to sorafenib treatment, supporting MTCH2 as a
Pu Xing, Jiangbo Chen, Hao Hao, Xiaowen Qiao, Xinying Yang, Kai Weng, Jie Chen, Lin Song, Tianqi Liu, Yifan Hou, Tongkun Song, Yumeng Ran, Bo Chen, Hong Yang, Wei Zhao, Zaozao Wang, Jiabo Di, Beihai Jiang, Xiangqian Su   +18 more
wiley   +1 more source

Correction to: Adherence to multi‑target stool DNA testing for colorectal cancer screening in the United States. [PDF]

Int J Colorectal Dis
Le QA, Greene M, Gohil S, Ozbay AB, Dore M, Fendrick AM, Limburg P.   +6 more
europepmc   +1 more source

“Virtual” or conventional colonoscopy for colorectal cancer screening (CRCS): How might primary care physicians (PCP) advise their patients?

, 2000
T L Angtuaco, Geraldine D. Banaad, Raywin Huang, Colin W. Howden   +3 more
openalex   +1 more source